Beasley R - Search Results

1

Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data.

DuMouchel W, Smith ET, Beasley R, Nelson H, Yang X, Fram D, Almenoff JS. DuMouchel W, et al. Among authors: beasley r. Clin Ther. 2004 Jul;26(7):1092-1104. doi: 10.1016/s0149-2918(04)90181-6. Clin Ther. 2004. PMID: 15336474 Review.

2

Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database.

Bibby S, Healy B, Steele R, Kumareswaran K, Nelson H, Beasley R. Bibby S, et al. Among authors: beasley r. Thorax. 2010 Feb;65(2):132-8. doi: 10.1136/thx.2009.120972. Thorax. 2010. PMID: 20147592

3

Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.

Beasley RW, Donohue JF, Mehta R, Nelson HS, Clay M, Moton A, Kim HJ, Hederer BM. Beasley RW, et al. BMJ Open. 2015 Feb 3;5(2):e006131. doi: 10.1136/bmjopen-2014-006131. BMJ Open. 2015. PMID: 25649209 Free PMC article. Clinical Trial.

4

Nebulized beta 2-adrenoceptor agonists do not affect plasma selenium or glutathione peroxidase activity in patients with asthma.

Burgess CD, Bremner P, Thomson CD, Crane J, Siebers RW, Beasley R. Burgess CD, et al. Among authors: beasley r. Int J Clin Pharmacol Ther. 1994 Jun;32(6):290-2. Int J Clin Pharmacol Ther. 1994. PMID: 7921529 Clinical Trial.

5

Albuterol and deaths from asthma in New Zealand from 1969 to 1976: a case-control study.

Woodman K, Pearce N, Beasley R, Burgess C, Crane J. Woodman K, et al. Among authors: beasley r. Clin Pharmacol Ther. 1992 May;51(5):566-71. doi: 10.1038/clpt.1992.64. Clin Pharmacol Ther. 1992. PMID: 1587070

6

The pulmonary and extrapulmonary effects of inhaled beta-agonists in patients with asthma.

Windom HH, Burgess CD, Siebers RW, Purdie G, Pearce N, Crane J, Beasley R. Windom HH, et al. Among authors: beasley r. Clin Pharmacol Ther. 1990 Sep;48(3):296-301. doi: 10.1038/clpt.1990.152. Clin Pharmacol Ther. 1990. PMID: 1976051 Clinical Trial.

7

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K. Humbert M, et al. Among authors: beasley r. Allergy. 2005 Mar;60(3):309-16. doi: 10.1111/j.1398-9995.2004.00772.x. Allergy. 2005. PMID: 15679715 Clinical Trial.

8

Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?

Beasley R, Pearce N, Crane J, Burgess C. Beasley R, et al. J Allergy Clin Immunol. 1999 Aug;104(2 Pt 2):S18-30. doi: 10.1016/s0091-6749(99)70270-8. J Allergy Clin Immunol. 1999. PMID: 10452785 Review.

9

The risk of asthma mortality with inhaled long acting beta-agonists.

Wijesinghe M, Perrin K, Harwood M, Weatherall M, Beasley R. Wijesinghe M, et al. Among authors: beasley r. Postgrad Med J. 2008 Sep;84(995):467-72. doi: 10.1136/pgmj.2007.067165. Postgrad Med J. 2008. PMID: 18940948 Review.

10

Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy.

Weatherall M, Wijesinghe M, Perrin K, Harwood M, Beasley R. Weatherall M, et al. Among authors: beasley r. Thorax. 2010 Jan;65(1):39-43. doi: 10.1136/thx.2009.116608. Thorax. 2010. PMID: 20029037

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

917 results

Search Page